Market Update
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Anagenics Limited has announced a restructuring update regarding the sale of its Face MediGroup business to its co-founders, which will allow the company to exit this segment and reduce operating costs. The transaction involves the assumption of liabilities and cancellation of a deferred payment obligation, with no cash exchanged at settlement.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/market-update-166
Earlier from Anagenics
- Suspension from Official Quotation
- Pause in Trading
- FY24 4E Presentation
- Appendix 4E and Preliminary Final Report
- Company Update License Partnership Announcement
Later from Anagenics
- 2024 Anagenics Annual Report
- Q1 F25 Activity Statement and Appendix 4C
- Restructuring Update & Resignation of Director
- Q2 F25 Activity Statement and Appendix 4C
- Update on 2Q25 Activity Report
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics